1-10 of 10
Elena Pérez
Close
Sort by
Journal Articles

Relinf Registry-Based Analysis Shows Overall Survival Improvement with New Therapies for Relapsed or Refractory Large B-Cell Lymphoma: A Study from the Geltamo Group

Mariana Bastos-Oreiro, Pau Abrisqueta Costa, Antonio Gutierrez, Ana Jimenez Ubieto, Maria Pozas, Sonia Gonzalez De Villambrosia, Raul Cordoba, Alberto Lopez Garcia, Elena Perez Ceballos, Belen Navarro, Ana Muntanola, Eva Donato, Eva Diez-baeza, Maria Lourdes Escoda Teigell, Hugo Daniel Luzardo Henriquez, María Peñarrubia-Ponce, Daniel Garcia Belmonte, Emilia Pardal, Claudia Lozada, Armando Lopez-Guillermo, Alejandro Martín García-Sancho
Journal: Blood
Blood (2023) 142 (Supplement 1): 4870.
https://doi.org/10.1182/blood-2023-186594
Published: 2023
Journal Articles

High frequency of low-count monoclonal B-cell lymphocytosis in hospitalized COVID-19 patients

Clinical Trials & Observations
Guillermo Oliva-Ariza, Blanca Fuentes-Herrero, Cristina Carbonell, Quentin Lecrevisse, Alba Pérez-Pons, Alba Torres-Valle, Julio Pozo, José Ángel Martín-Oterino, Óscar González-López, Amparo López-Bernús, Marta Bernal-Ribes, Moncef Belhassen-García, Oihane Pérez-Escurza, Martín Pérez-Andrés, Lourdes Vazquez, Guillermo Hernández-Pérez, Francisco Javier García Palomo, Pilar Leoz, Pilar Costa-Alba, Elena Pérez-Losada, Ana Yeguas, Miryam Santos Sánchez, Marta García-Blázquez, Francisco Javier Morán-Plata, Daniela Damasceno, Vitor Botafogo, Noemí Muñoz-García, Rafael Fluxa, Teresa Contreras-Sanfeliciano, Julia Almeida, Miguel Marcos, Alberto Orfao
Journal: Blood
Blood (2023) 141 (3): 309–314.
https://doi.org/10.1182/blood.2022017439
Published: 2023
Includes: Supplemental data
Journal Articles

Impact on Survival of the Introduction of New Therapies for Relapsed-Refractory Aggressive B-Cell Lymphoma, Based on the Relinf Registry: A Study By the Spanish Geltamo Group

Mariana Bastos-Oreiro, Ana Jimenez-Ubieto, Sonia González de Villambrosia, Raul Cordoba, Elena Pérez Ceballos, EVA Maria DONATO Martin, Ana Muntañola Prat, Hugo Daniel Luzardo Henriquez, Lourdes Escoda, Maria Jesús Peñarrubia, María Pozas, Alberto Lopez-Garcia, Daniel Garcia, Emilia Pardal, Claudia Salazar Lozada, Alejandro Martín García-Sancho
Journal: Blood
Blood (2022) 140 (Supplement 1): 9501–9503.
https://doi.org/10.1182/blood-2022-166213
Published: 2022
Journal Articles

Clinical Features and Outcome of Patients with Castleman Disease Subtypes: A Spanish Multicentric Study of 145 Patients from Geltamo

Jose Tomas Navarro, Carolina Celades, Andrea Usas, Olga García, Eva Gonzalez Barca, Fina Climent, Andrea Feu, Ana Isabel Jiminez Ubieto, Alba Gutiérrez de la Peña, Mariana Bastos-Oreiro, Teresa Aldamiz-Echevarría, Antonio Gutierrez, Leyre Bento De Miguel, Pau Abrisqueta Costa, Carmen Alonso Prieto, Christian David Tejada Chaves, Enrique M. Ocio, Noemi Fernandez-Escalada, Belén Navarro, José Miguel Mateos Pérez, Andrea Rivero, Carlos Fernández De Larrea, Alberto Lopez-Garcia, Paola Sandra Villafuerte Gutierrez, Sergio Felipe Pinzón, Elena Pérez Ceballos, Andrés González, José Ángel Hernández-Rivas, Raquel Del Campo, Emilia Pardal, Ramón García-Sanz, Jordina Rovira Sole, Juan-Manuel Sancho, Gustavo Tapia
Journal: Blood
Blood (2022) 140 (Supplement 1): 9342–9344.
https://doi.org/10.1182/blood-2022-163165
Published: 2022
Journal Articles

Incidence and Prognostic Impact of Secondary Neoplasia after High Dose Therapy Supported By Autologous Stem Cell Transplantation in Follicular Lymphoma. a Long Term Follow-up Analysis from the Geltamo Registry

ANA Jimenez Ubieto, MD PhD, Carlos Grande, MD, Dolores Caballero, MD PhD, Lucrecia Yañez, MD PhD, Silvana Novelli, MD, Miguel-Teodoro Hernández, Marina Manzanares, Reyes Arranz, MD, José Javier Ferreiro, Sabella Bobillo, Santiago Mercadal, MD, Andrea Galeo, Javier Lopez-Jimenez, MD, Jose Maria Moraleda, MD PhD, Carlos Vallejo, Carmen Albo, MD, Elena Pérez, Carmen Marrero, Laura Magnano, MD, Luis Palomera, MD PhD, Isidro Jarque, MD, Pilar Martínez-Sánchez, MD, Alejandro Martín, MD PhD, Erika Coria, Armando López-Guillermo, Antonio Salar, MD PhD, Juan José Lahuerta, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3451.
https://doi.org/10.1182/blood.V128.22.3451.3451
Published: 2016
Journal Articles

Progression-Free Survival at 24 Months (PFS24) and Complete Response at 30 Months (CR30) from Autologous Stem Cell Transplantation (ASCT) Should be Used As Surrogates for OS in Follicular Lymphoma (FL) Patients

Ana Jiménez Ubieto, Carlos Grande García, Lucrecia Yañez, Dolores Caballero, MD, Silvana Novelli, MD, María Jesús Rodriguez, Marina Manzanares, Reyes Arranz, MD, José Javier Ferreiro, Sabela Bobillo, Santiago Mercadal, MD, Andrea Galego, Javier López Jiménez, Carlos Vallejo, Carmen Albo, Elena Pérez, Carmen Marrero, Laura Magnano, Luis Palomera, MDPhD, Isidro Jarque, Erika Coria, Teresa Palomo, Pilar Martinez Sánchez, Armando López-Guillermo, Antonio Salar, MD PhD, Juan José Lahuerta
Journal: Blood
Blood (2015) 126 (23): 521.
https://doi.org/10.1182/blood.V126.23.521.521
Published: 2015
Journal Articles

High Dose Therapy with Autologous Stem Cell Transplantation (HDT/ASCT) Support in Follicular Lymphoma (FL) a Very Long Follow-up Analysis of 640 Patients of Geltamo Spanish Group Suggests That FL Might be Cured, Even in High-Risk Patients

Ana Jiménez Ubieto, Carlos Grande García, MD, Lucrecia Yáñez, MD, Dolores Caballero, Silvana Novelli, MD, María Jesús Rodriguez, María Manzanares, Reyes Arranz, MD PhD, Jose Javier Ferreiro, MD, Sabella Bobillo, Santiago Mercadel, Andrea Galeo, Javier López, Carlos Vallejo, Carmen Albo, Elena Perez, Carmen Marrero, MD, Laura Magnano, MD, Luis Palomera, Isidro Jarque, Erika Coria, Teresa Palomo, Juan José Lahuerta, MD PhD, Armando Lopez-Guillermo, Antonio Salar, MD
Journal: Blood
Blood (2014) 124 (21): 675.
https://doi.org/10.1182/blood.V124.21.675.675
Published: 2014
Journal Articles

Salvage Treatment with Ofatumumab and ESHAP (O-ESHAP) for Patients with Relapsed or Refractory Classical Hodgkin's Lymphoma After First-Line Chemotherapy: Interim Analysis of a Phase II Trial of the Spanish Group of Lymphoma and Bone Marrow Transplantation (GELTAMO)

Carmen Martinez, MD, Mercedes Rodriguez-Calvillo, María José Terol, MD, PhD, Blanca Xicoy, MD, PhD, Ramón García-Sanz, Elena Perez-Ceballos, Alberto Cantalapiedra, Eva Domingo-Domènech, MD, Miguel Hernández, Antonia Sampol, MD, Manuel Espeso, Javier Briones, MD, Javier Lopez, Anna Sureda, MD
Journal: Blood
Blood (2012) 120 (21): 1630.
https://doi.org/10.1182/blood.V120.21.1630.1630
Published: 2012
Journal Articles

Antithrombin Cambridge II (A384S): an underestimated genetic risk factor for venous thrombosis

Clinical Trials & Observations
Javier Corral, David Hernandez-Espinosa, Jose Manual Soria, Rocio Gonzalez-Conejero, Adriana Ordonez, Jose Ramon Gonzalez-Porras, Elena Perez-Ceballos, Ramon Lecumberri, Ignacio Sanchez, Vanessa Roldan, Jose Mateo, Antonia Minano, Marcos Gonzalez, Ignacio Alberca, Jordi Fontcuberta, Vicente Vicente
Journal: Blood
Blood (2007) 109 (10): 4258–4263.
https://doi.org/10.1182/blood-2006-08-040774
Published: 2007
Journal Articles

Follicular Lymphoma: Design of a Protein-Based Survival Predictor Using Tissue-Microarrays (TMA).

Francisca I. Camacho, MD, Reyes Arranz-Saez, MD, Alessia Caleo, MD, Jimena Cannata, MD, Laura Cereceda, Leocricia Gonzalez, MD, Mª Elena Perez-Martin, MD, Lydia Sanchez-Verde, PhD, Carlos Montalban, MD, Juan F. Garcia, MD, Miguel A. Piris, MD, Carmen Bellas, PhD
Journal: Blood
Blood (2004) 104 (11): 2266.
https://doi.org/10.1182/blood.V104.11.2266.2266
Published: 2004